GT
RGEN icon

Greenleaf Trust’s Repligen RGEN Stock Holding History

Greenleaf Trust’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,516
Closed -$226K – 851
2024
Q3 		$226K Buy
+1,516
New +$217K ﹤0.01% 758
2024
Q2 		– Sell
-1,369
Closed -$252K – 820
2024
Q1 		$252K Buy
1,369
+53
+4% +$10.1K ﹤0.01% 664
2023
Q4 		$237K Sell
1,316
-567
-30% -$88.3K ﹤0.01% 658
2023
Q3 		$299K Sell
1,883
-37
-2% -$6.05K ﹤0.01% 578
2023
Q2 		$272K Buy
1,920
+432
+29% +$69.3K ﹤0.01% 625
2023
Q1 		$251K Buy
1,488
+102
+7% +$18.2K ﹤0.01% 656
2022
Q4 		$235K Sell
1,386
-85
-6% -$15.4K ﹤0.01% 664
2022
Q3 		$275K Buy
1,471
+41
+3% +$8.65K ﹤0.01% 568
2022
Q2 		$232K Sell
1,430
-144
-9% -$22.8K ﹤0.01% 637
2022
Q1 		$296K Sell
1,574
-67
-4% -$12.7K ﹤0.01% 599
2021
Q4 		$435K Buy
1,641
+261
+19% +$70.3K 0.01% 466
2021
Q3 		$399K Buy
1,380
+55
+4% +$14.1K ﹤0.01% 474
2021
Q2 		$264K Sell
1,325
-22
-2% -$4.27K ﹤0.01% 622
2021
Q1 		$262K Buy
1,347
+70
+5% +$14.4K ﹤0.01% 601
2020
Q4 		$245K Buy
+1,277
New +$232K ﹤0.01% 530

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Greenleaf Trust's RGEN Position: Q4 2024 in Review

Greenleaf Trust sold out of Repligen (RGEN) in Q4 2024, closing a stake of 1,516 shares — an estimated $226K sold.

Greenleaf Trust first reported a position in RGEN in Q4 2020 and held it in 15 quarters. The position peaked at $435K in Q4 2021. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • Greenleaf Trust reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • Greenleaf Trust sold 1,516 Repligen shares in Q4 2024, an estimated $226K.
  • Greenleaf Trust first reported a position in Repligen in Q4 2020 and held it in 15 quarters.
  • Greenleaf Trust's Repligen position peaked at $435K in Q4 2021.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Greenleaf Trust's 13F filing for Q4 2024, filed 24 Jan 2025.